BioSpace News Archive

Clearside Biomedical, Inc. announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, will participate in a fireside chat at the Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023 at 8:35 a.m. ET in New York, NY.

Forward Therapeutics, Inc. today announced a $50 million Series A financing.

BridgeBio Pharma, Inc. today announced that on November 07, 2023, the compensation committee of BridgeBio’s board of directors granted thirty-three new employees restricted stock units for an aggregate of 183,533 shares of the Company’s common stock.

Supernus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, announced financial results for the third quarter of 2023, and associated Company developments.

Biomea Fusion, Inc. announced that the abstract showing long-term 26 weeks follow-up data of the first 20 patients from the first two dosing cohorts of COVALENT-111 has been accepted for the 2023 Poster Session of the 21st World Congress Insulin Resistance, Diabetes & Cardiovascular Disease taking place on December 7-9.

Dyadic International, Inc. announced its financial results for the third quarter of 2023, and highlighted recent company developments.

Neurocrine Biosciences, Inc. announced the availability of DISCOVER TD™, an interactive digital tool designed to help healthcare providers learn about and identify tardive dyskinesia.

Jazz Pharmaceuticals plc announced financial results for the third quarter of 2023 and provided business updates.

Equillium, Inc. announced financial results for the third quarter 2023 and provided corporate and clinical development updates.

Revance Therapeutics, Inc. announced the appointment of Erica Jordan, Senior Vice President of Commercial to Chief Commercial Officer, Aesthetics.